Wei Li Lin
Director/Board Member bei HANDA PHARMACEUTICALS, INC.
Profil
Wei Li Lin is currently the Chairman of Chuan Fa Biotechnology Co. Ltd., Director-Supervisory Board of Microbio (Shanghai) Co., Ltd., and an Independent Director at Handa Pharmaceuticals, Inc. He previously served as Chairman, President & Spokesman at Fountain Biopharma, Inc. and as a Director at OBI Pharma, Inc. Dr. Lin holds a doctorate degree from Kansas State University.
Aktive Positionen von Wei Li Lin
| Unternehmen | Position | Beginn |
|---|---|---|
| HANDA PHARMACEUTICALS, INC. | Director/Board Member | 28.09.2017 |
| Microbio (Shanghai) Co., Ltd. | Director/Board Member | - |
| Chuan Fa Biotechnology Co. Ltd. | Chairman | - |
Ehemalige bekannte Positionen von Wei Li Lin
| Unternehmen | Position | Ende |
|---|---|---|
| OBI PHARMA, INC. | Director/Board Member | 20.12.2012 |
| FOUNTAIN BIOPHARMA INC | Chairman | - |
Ausbildung von Wei Li Lin
| Kansas State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OBI PHARMA, INC. | Health Technology |
| HANDA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Microbio (Shanghai) Co., Ltd. | |
Fountain Biopharma, Inc.
 Fountain Biopharma, Inc. Pharmaceuticals: OtherHealth Technology Fountain Biopharma, Inc. engages in the research, development and sales of antibody drugs. Its products include anti-allergic monoclonal antibody drugs, monoclonal antibody drugs, immune checkpoint aptamer drugs, anti-lag-3 immunological checkpoint aptamer drugs and anti-tumor stem cell labeled antibody drugs. The company was founded on November 25, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |
| Chuan Fa Biotechnology Co. Ltd. |
